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Abstract
Background: The existing literature contains no information regarding inflammatory cytokine expression in
unilateral acute primary angle-closure (APAC) affected eyes and fellow eyes with primary angle closure suspect
(PACS). To measure levels of various inflammatory cytokines in the aqueous humor (AH) of APAC affected eyes and
fellow eyes with a diagnosis of PACS (18 unilateral APAC eyes and 18 fellow eyes with PACS), and determine the
underlying correlation between them.
Methods: The total levels of 12 cytokines including granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6,
IL-8, monocyte chemotactic protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC), macrophage
inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF) etc. were assessed using the multiplex
bead immunoassay technique. The level of cytokines in different groups was analyzed by a 2-related-samples
nonparametric test. Data on patient demographics, preoperative intraocular pressure (IOP), number of glaucoma
medications, as well as several ocular biological parameters were also collected for correlation analysis.
Results: The APAC patients had significantly higher levels of G-CSF, IL-6, IL-8, MCP-1, MCP-3, MDC, MIP-1β, and
VEGF in the AH samples from unilateral APAC affected eyes than in fellow eyes with PACS (all P < 0.05). The
cytokines showed positive correlations between each other (P < 0.0071).
Conclusions: Cytokine networks in the AH may have critical roles in the progression of APAC. Thus, different
cytokine expression in both eyes of the same patient may help us to understand the different pathology in APAC
and PACS.
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Background
Acute primary angle-closure (APAC) presents with typ-
ical symptoms and clinical signs such as sudden onset of
ocular discomfort or pain, subjective blurring of vision,
and suddenly excessive increases in intraocular pressure
(IOP). In APAC, the position of the iris causes the nor-
mally open anterior chamber angle to close. Aqueous
humor (AH) that should normally drain out of the an-
terior chamber is then trapped inside the eye, increasing
the IOP [1].
The AH plays an important role in the pathogenesis of
glaucoma [2]. Furthermore, AH has the task of pro-
tecting and supplying nutrients and antioxidants to the
cornea, lens, and trabecular meshwork (TM) [3, 4]. A
number of cytokines, including transforming growth fac-
tor (TGF-β2), interleukin (IL-6, and IL-8), have been
detected in the AH [5, 6]. Several studies that measured
cytokine concentrations in AH samples have revealed
significantly high levels in primary open angle glaucoma,
exfoliation glaucoma [7], and primary angle closure glau-
coma [8].
By 2020, it is estimated almost 80 million persons will
have glaucoma worldwide. Particularly in Asian coun-
tries, angle closure glaucoma accounts for no less than
half of the blindness arising from glaucoma. Therefore,
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more attention needs to be paid to APAC in China. In
our previous report, compared with the cataract group,
APAC showed clear and significantly elevated concentra-
tions of IL-6, IL-8, granulocyte colony-stimulating factor
(G-CSF), monocyte chemotactic protein (MCP)-1, MCP-
3, and vascular endothelial growth factor (VEGF) [9].
However, the existing literature contains no information
regarding inflammatory cytokine expression in unilateral
APAC affected eyes and fellow eyes with primary angle-
closure suspect (PACS).
In this study, we want to exlore whether some differ-
ent inflammation-related cytokines expressed in APAC
compared with fellow eyes with PACS and whether there
are novel findings different from those previously pub-
lished by Huang et al. [9]. Huang’s previous report have
measured levels of various inflammation-related cyto-
kines in the aqueous humor of patients with acute pri-
mary angle-closure (APAC) and senile cataract. The
present study want to explore different inflammatory
cytokine expression in unilateral acute primary angle-
closure (APAC) affected eyes and fellow eyes with pri-
mary angle closure suspect (PACS). The design of fellow
eye comparison may help us to find novel things. Our
finding may expand the understanding of asymmetric
glaucoma pathophysiology.
Methods
Subjects and enrollment criteria
Participants in this study were selected as a conveni-
ence sample of patients at the Glaucoma Department,
Zhongshan Ophthalmic Center. Both eyes of each
subject were included. All enrolled glaucoma patients
fulfilled the following criteria: Subjects were > 18 years
old. APAC was defined according to the following cri-
teria: [10] ➀ Presence of at least two of the following
symptoms: ocular or periocular pain, nausea and/or
vomiting, and an antecedent history of intermittent
blurring of vision with halos; ➁ IOP of at least 22 mm Hg
(as measured by Goldmann applanation tonometry); ➂
presence of at least three of the following signs of con-
junctival injection: corneal epithelial edema, mid-dilated
unreactive pupil, and a shallow anterior chamber; and ➃
presence of an occluded angle in the affected eye, verified
by gonioscopy. Ultrasound biomicroscopy (UBM) examin-
ation confirmed that a narrow-angle pupillary block com-
ponent existed in all eyes. PACS fulfilled the following
criteria: ➀narrow angles (defined as eyes in which at least
180°of the posterior pigmented trabecular meshwork was
not visible on gonioscopy in the primary position of
gaze without indentation); ➁ IOP less than or equal
to 21 mmHg ➂ healthy optic disc; ➃ without primary
angle closure [11].
The AH collection was performed under sterile condi-
tions via an anterior chamber paracentesis or peripheral
iridectomy, or before commencement of surgery for all
trabeculectomy-required patients, and their fellow PACS
eyes were scheduled for prophylactic surgical peripheral
iridectomy according to agreements of the patients
and the requirements of the Chinese medical associ-
ation. These management recommendations are decided
according to the American Academy of Ophthalmology
Preferred Practice Pattern guidelines on primary angle
closure (http://www.aao.org) and individual situations.
The antiglaucomatous medication treatment for APAC
was standardized as follows: topical pilocarpine 1 % four
times daily; topical beta-blocker (timolol 0.5 %) twice daily
and/or brinzolamide (Azopt; Alcon Laboratories, Elkridge,
MD), and/or topical alpha-2 agonists (Alphagan; Allergan,
Inc., Irvine, CA); topical steroids; oral acetazolamide 250
mg three times daily and intravenous mannitol 20 % at 1
to 2 g/kg 4 h after the initiation of the treatment in cases
where the IOP was not reduced by 20 % from the initial
IOP, excluding contraindicated by systemic disease (e.g.,
congestive heart failure).
Patients who met any of the following criteria were
excluded: a secondary acute attack because of lens sub-
luxation, uveitis, iris neovascularization, trauma, tumor,
or any obvious cataract leading to an intumescent lens; a
known systemic inflammatory, autoimmune, or immuno-
suppressive disease; a pre-existing ocular disease (retinal
vein occlusion, retinal artery occlusion, diabetic retinop-
athy, age-related macular degeneration); or a history of
previous ocular surgery.
All eyes of the subjects underwent a thorough ophthalmic
evaluation, including slit-lamp biomicroscopy, IOP meas-
urement (Goldmann applanation tonometry), gonioscopy,
fundus examination, UBM, and B-scanning. IOP was mea-
sured preoperatively, mainly in the afternoon on the day be-
fore the AH sampling for all studied eyes. We believe that
this minimized the influences of diurnal variation of IOP
and closely reflected the IOP at the time of AH sampling.
Aqueous humor collection
The AH samples (50–100 μL) were collected by a proced-
ure described in our previous study [12]. Two AH samples
of APAC eyes were collected during an anterior chamber
paracentesis procedure, and 16 samples were collected at
the beginning of peripheral iridectomy or trabeculectomy.
The AH samples of PACS eyes were collected at the begin-
ning of peripheral iridectomy. All samples were obtained
prior to any conjunctival or intraocular manipulation to
avoid breakdown of the blood–aqueous barrier associated
with surgical trauma. All samples were immediately frozen
and stored at −80 °C until the analyses were performed.
Cytokine analysis
Cytokine concentrations were analyzed using a multiplex
bead immunoassay system (Milliplex Human Cytokine®
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kit; Millipore Corp., Billerica, MA). The assays were
performed according to the manufacturer’s instruc-
tions and analyzed using the Bio-Plex suspension
array system (Bio-plex200, Bio-Rad, Hercules, CA).
Cytokines related to the inflammatory process [G-
CSF, IL-6, IL-8, MCP-1, MCP-3, macrophage-derived
chemokine (MDC), MIP-1β, VEGF, GM-CSF (granulocyte-
macrophage, colony-stimulating factor), IFN-γ (interferon-
gamma), IL-1βand TNF-β (tumor necrosis factor-beta)]
were analyzed in a 25 μl volume of AH sample for each
reaction. Based on the information provided by the manu-
facturer, the multiplex assay kit can quantitatively measure
multiple cytokines from as little as 25 μL of body fluids.
The detection limit for any analyte was 1 pg⁄ml, with
a dynamic range up to 10000 pg⁄ml (according to the
manufacturer).
Statistical analysis
The data were processed and analyzed statistically using
SPSS (Version 13.0; SPSS, Chicago, IL). The level of cy-
tokines in different groups was analyzed by a 2-related-
samples nonparametric test. Statistical significance was
accepted at P < 0.05. Correlations among cytokines and
correlations between cytokine concentrations and sub-
jects’ demographic data (including age, IOP and anterior
chamber depth (ACD), lens thickness (LT) and vitreous
chamber depth (VCD) in the macular region) were calcu-
lated using Spearman’s correlation test. For the correction
of multi-group comparisons, P values of 0.0071 for
Spearman’s correlation test were considered statistically
significant, with significance levels of 0.05 based on
Bonferroni’s methods.
Ethics
This study was approved by the Ethical Review Commit-
tee of Zhongshan Ophthalmic Center and adhered to
the provisions of the Declaration of Helsinki for research
involving human subjects. All subjects participating in
this study were given a detailed explanation about the
study and signed an informed consent form. Participants
were recruited prospectively and consecutively for this
study, between January 2013 and May 2014. All subjects
were from a Chinese Han population.
Results
Patients’ demographic data
Eighteen APAC patients (18 unilateral APAC affected
eyes and 18 fellow eyes with PACS) who fulfilled the
inclusion criteria were included in the study.
The demographic data of the subjects, including age,
sex, number, and details of glaucoma medication use, are
summarized in Table 1. Biological parameters of APAC eyes
and PACS eyes are summarized in Table 2. The mean age
of the APAC patients was 63.80 ± 6.76 (mean ± standard
deviation) years. Data for duration of experienced attack,
number of glaucoma medications, IOP at the day of sur-
gery, Axial Length (AL), ACD, LT and VCD are expressed
as the median [IQ]. IOP on the day of surgery was higher
in the APAC eyes than in PACS eyes as determined
by a 2-related-samples nonparametric test (P = 0.008).
The comparison of cytokines between APAC eyes and
PACS eyes
GM-CSF, IFN-γ, IL-1β, and TNF-β were detected in less
than 50 % of samples in both control and glaucoma
groups and therefore were not included in further ana-
lysis. The concentrations of the remaining eight cyto-
kines analyzed are shown in Table 3. All measurements
were performed successfully. In the APAC patients, the
levels of G-CSF (P = 0.001), IL-6 (P = 0.000), IL-8 (P =
0.000), MCP-1 (P = 0.000), MCP-3 (P = 0.008), MDC
(P = 0.009), MIP-1β (P = 0.001), and VEGF (P = 0.035)
in AH samples from unilateral APAC affected eyes
were significantly higher than those from fellow eyes
with PACS (Fig. 1).
The correlations among different cytokine concentrations
The correlations among the different cytokine concen-
trations are shown in Table 4. Among seven cytokines
(G-CSF, IL-6, IL-8, MCP-1, MCP-3, MDC, and macro-
phage inflammatory protein (MIP-1β) positive cor-
relations were found between each other (P < 0.0071).
Table 1 Demographic and baseline characteristics of patients
Characteristics Subjects of study
No. of patients (No. of eyes) 18 (36)
Age, y (mean [SD]) 63.80 (6.76)
Sex (male/female) 5/13
Laterality of affected eye, right/left 7/11
Duration of experienced attack, d (median [IQ]) 5.50 (8.25)
No. of glaucoma medications in APAC eyes,
n (median [IQ])
1.00 (1.00)
SD standard deviation, IQ inter-quartile
Table 2 Characteristics of Acute Primary Angle-Closure Eyes






IOP at the day of surgery, mmHg 19.5 (20.68) 13.5 (6.0) 0.008*
Axial Length (AL), mm 22.42 (1.50) 22.25 (1.26) 0.138
Anterior Chamber
Depth (ACD), mm
2.24 (0.21) 2.22 (0.28) 0.236
Lens Thickness (LT), mm 5.17 (0.61) 5.29 (0.67) 0.244
Vitreous Chamber
Depth (VCD), mm
14.96 (1.35) 14.91 (1.32) 0.206
Data are expressed as the median (IQ). P-values were obtained from 2-related-
samples nonparametric test. * P-value < 0.05 was considered to be significant
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Table 3 Level of cytokines in aqueous humor from APAC eyes and fellow eyes with PACS
Affected eyes, APAC (pg/ml) Fellow eyes, PACS (pg/ml) P value
G-CSF 1608.42 (13.71; 0.00, 17420.00) 1.11 (0.00; 0.00, 13.58) 0.001*
IL-6 520.24 (14.62; 0.00, 3470.00) 0.35 (0.00; 0.00, 1.82) 0.000*
IL-8 160.37 (23.28; 0.00, 1043.00) 2.96 (1.09; 0.00, 13.64) 0.000*
MCP-1 2537.39 (1507.50; 696.75, 7384.00) 641.71 (661.50; 281.49, 1051.00) 0.000*
MCP-3 9.30 (6.45; 0.00, 50.90) 2.34 (0.49; 0.00, 7.35) 0.008*
MDC 38.80 (5.60; 0.00, 268.00) 10.98 (3.61; 0.00, 50.00) 0.009*
MIP-1β 23.67 (21.21; 0.00, 63.10) 3.95 (0.16; 0.00, 21.07) 0.001*
VEGF 701.60 (120.43; 0.00, 5162.00) 93.87 (91.01; 0.00, 182.00) 0.035*
APAC acute primary angle-closure; PACS primary angle-closure suspect. Granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-8, monocyte chemotactic
protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC), macrophage inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF). Data
are expressed as the mean (median; range). P-values were obtained from 2-related-samples nonparametric test.* P-value <0.05 was considered to be significant
Fig. 1 Differences of cytokines in APAC with PACS. Scatterplots showing distribution levels of G-CSF, IL-6, IL-8, MCP-1, MCP-3, MDC, MIP-1β, and
VEGF in aqueous humor from unilateral acute primary angle-closure (APAC) affected eyes and fellow eyes with primary angle-closure suspect
(PACS). Two-related-samples nonparametric test was performed between groups, and a significant difference was accepted at P < 0.05. The solid
lines indicate median concentrations. In the APAC patients, the levels of G-CSF (P = 0.001), IL-6 (P = 0.000), IL-8 (P = 0.000), MCP-1 (P = 0.000), MCP-3
(P = 0.008), MDC (P = 0.009), MIP-1β (P = 0.001), and VEGF (P = 0.035) in AH samples from unilateral APAC affected eyes were significantly higher than
those from fellow eyes with PACS
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Negative correlations were found between VEGF and G-
CSF (ρ = 0.307; P = 0.068), VEGF and MCP-3 (ρ = 0.434;
P = 0.008), and VEGF and MDC (ρ = 0.250; P = 0.141).
The correlations between each cytokine and age, IOP, the
number of glaucoma medications, and some ocular
biological parameters in APAC patients
The correlations between each cytokine and age, IOP,
number of Glaucoma Medications, AL, ACD, LT, and
VCD in APAC patients are shown in Table 5. Positive
correlations existed between IOP and G-CSF (ρ = 0.506;
P = 0.002). The number of glaucoma medications was
positively correlated with G-CSF (ρ = 0.464; P = 0.004), IL-
6 (ρ = 0.443; P = 0.007), and IL-8 (ρ = 0.439; P = 0.007).
Discussion
The bead immunoassay revealed that the levels of G-
CSF, IL-6, IL-8, MCP-1, MCP-3, MDC, MIP-1β, and
VEGF were significantly higher in AH samples from uni-
lateral APAC affected eyes than from fellow eyes with
PACS. Clear elevations of cytokines related to an im-
mune reaction or inflammation existed in AH samples
from APAC eyes. This is one of the earliest studies to
report successful detection of multiple cytokines with
the method of the multiplex bead immunoassay in AH
samples from APAC and PACS eyes. A previous study
showed that normal TME cells constitutively secreted
chemotactic cytokines like IL-8 and MCP-1. Secretion of
these chemokines was augmented by treatment with the
pro-inflammatory cytokines or other stimulations [13].
IL-8, also called chemokine (C-X-C motif ) ligand-8
(CXCL8), is a member of the CXC family of chemokines
and is known to have both immune and vascular func-
tions [14, 15]. Multiple studies have demonstrated an
elevation of IL-8 under suboptimal oxygenation con-
ditions, which suggests a possible mechanism for the
increased IL-8 found in our study of APAC patients
[5, 16]. The concentration of the inflammatory cytokine
IL-8 was significantly elevated in the AH of primary
open angle glaucoma (POAG) patients, supporting the
Table 4 Correlations among cytokines
ρ/P value G-CSF IL-6 IL-8 MCP-1 MCP-3 MDC MIP-1β VEGF
G-CSF — 0.829 0.726 0.696 0.785 0.547 0.608 0.307
IL-6 0.000* — 0.811 0.886 0.703 0.549 0.647 0.480
IL-8 0.000* 0.000* — 0.785 0.715 0.647 0.841 0.512
MCP-1 0.000* 0.000* 0.000* — 0.649 0.461 0.631 0.515
MCP-3 0.000* 0.000* 0.000* 0.000* — 0.500 0.607 0.434
MDC 0.001* 0.001* 0.000* 0.005* 0.002* — 0.461 0.250
MIP-1β 0.000* 0.000* 0.000* 0.000* 0.000* 0.005* — 0.472
VEGF 0.068 0.003* 0.001* 0.001* 0.008 0.141 0.004* —
Granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC),
macrophage inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF)
Correlation coefficient (ρ) and P values are calculated by Spearman’s correlation
*Significance level at 5 % (P < 0.0071) by Bonferroni correction for multiple comparisons
Table 5 Correlations between Cytokines and relevant factors in APAC patients
Age IOP Number of Glaucoma Medications AL ACD LT VCD
ρ P value ρ P value ρ P value ρ P value ρ P value ρ P value ρ P value
G-CSF −0.232 0.173 0.506 0.002* 0.464 0.004* −0.060 0.729 −0.074 0.670 0.121 0.482 −0.097 0.572
IL-6 −0.115 0.503 0.424 0.010 0.443 0.007* −0.089 0.605 0.031 0.860 0.040 0.815 −0.132 0.444
IL-8 −0.143 0.406 0.375 0.024 0.439 0.007* −0.198 0.246 0.056 0.743 0.004 0.980 −0.201 0.239
MCP-1 −0.097 0.573 0.291 0.085 0.285 0.092 −0.110 0.523 0.040 0.817 −0.002 0.989 −0.140 0.414
MCP-3 −0.127 0.460 0.420 0.011 0.347 0.038 −0.040 0.816 0.005 0.977 0.177 0.300 −0.108 0.531
MDC −0.261 0.125 0.201 0.240 0.131 0.445 −0.411 0.013 0.193 0.259 −0.182 0.288 −0.364 0.029
MIP-1β −0.166 0.335 0.387 0.020 0.395 0.017 −0.130 0.450 0.003 0.985 0.029 0.865 −0.126 0.463
VEGF 0.013 0.941 0.318 0.058 0.198 0.247 −0.051 0.769 −0.091 0.597 0.300 0.075 −0.185 0.280
Relevant factors: Age, intraocular pressure (IOP), Number of Glaucoma Medications, Axial Length (AL), Anterior Chamber Depth (ACD), Lens Thickness (LT), Vitreous
Chamber Depth (VCD) and Choroidal Thickness in the Macular Region (CT)
Granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC),
macrophage inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF)
Correlation coefficient (ρ) and P values are calculated by Spearman’s correlation
*Significance level at 5 % (P < 0.0071) by Bonferroni correction for multiple comparisons
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hypothesis that immune activation occurs during
glaucoma [5, 7]. A study by Kuchtey et al. also dem-
onstrated a significantly higher IL-8 concentration in
the more severely affected eyes of the patients with
asymmetric glaucoma [5]. The present study showed
that IL-8 was higher in the APAC eyes than the fellow
eyes with PACS. In an acute attack of glaucoma immuno-
logical activation probably has nothing to do. It is evident
that if the iris touches the trabecular meshwork occurs
inflammation, but then it is possible that this will stimu-
late the production of this cytokine because the outflow is
hampered. In fact, IL-8 modulates the permeability of the
Schlemm’s canal endothelial cells reported by Alvarado et
al. [17]. Therefore, it is more plausible that the IL-8 pres-
ence in APAC eyes is due to the attempt by the tra-
becular meshwork to increase the outflow is
hampered [18].
Furthermore, monocytes, presumably under the influ-
ence of chemotactic signals, circulate through the tra-
becular meshwork in the normal state and also that
cytokines regulate the permeability of Schlemm’s canal
endothelial cells [19]. Therefore, the increase of MCP-1
should be viewed in the same way or to attempt to do
work better than the outflow of the trabecular mesh-
work. Also the granulocyte colony-stimulating factor is
produced by the TM endothelial cells and probably
works as a reminder for the stem cells of the TM, be-
cause in an acute attack of glaucoma occurs severe suf-
fering of the TM endothelial cells.
VEGF was another important cytokine investigated in
this study, and its level was significantly higher in APAC
eyes. Previous studies have detected VEGF protein in
AH from eyes with POAG, angle closure glaucoma, and
exfoliation glaucoma (EXG) [20]. Although the study by
Takai et al. reported a mean difference in the level of
VEGF that did not reach significance, the level was
higher in the EXG group [7]. Another study reported a
significant association between VEGF and the final IOP
in patients with POAG [21]. The study by Kim et al.
reported that the level of VEGF in the AH was signifi-
cantly higher in the failure group after the Ahmed glau-
coma implantation compared with the success group,
implying that VEGF may play a role in determining sur-
gical success after Ahmed valve implantation in patients
with neovascular glaucoma (NVG) [22]. VEGF expres-
sion can be induced by subjecting cells to hypoxia or
hypoglycemia [23]. In this present study, our findings for
VEGF suggest that an anoxic environment possibly plays
a key role in the pathogenesis of glaucoma and in surgi-
cal success.
The present study also indicated significant differences
in the levels of IL-6, MDC, and MIP-1β between APAC
eyes and PACS eyes. Some past studies found no signifi-
cant correlations for IL-6 levels in AH from POAG
patients [7, 24]. Interleukin-6 (IL-6) is a multi-functional
cytokine that regulates immune responses, acute
phase reactions, and hematopoiesis, and may play a
central role in host defense mechanisms. MDC is pro-
duced by both immune and nonimmune cells, usually
in response to inflammatory stimuli or tissue damage.
The study by Yin et al. suggested that macrophage-
derived factors stimulate optic nerve regeneration [25].
MIP-1β, which induces both chemotaxis and adhesion of
T cells [26], may play a key role in an immune reaction in
the APAC eyes.
The significant correlations among the cytokines (G-
CSF, IL-6, IL-8, MCP-1, MCP-3, MDC and MIP-1β) sug-
gested that the cytokine networks play important roles
in inflammation and IOP elevations in APAC, although
the exact mechanism of the interactions among these
cytokines are unclear. Therefore, evaluation of the AH
composition of various inflammatory cytokines may ex-
pand the understanding of APAC pathophysiology.
Other parameters, such as axial length of the eye, age,
and gender, may also affect the measured cytokine data
[27]. In the present study, the data for age, IOP, number
of glaucoma medications, AL, ACD, LT and VCD were
analyzed for correlations and statistically significant dif-
ferences were noted between G-CSF and IOP, G-CSF
and number of glaucoma medications, IL-6 and number
of glaucoma medications, and IL-8 and number of glau-
coma medications.
Although the exact mechanism of this interaction is
unclear, the IOP levels suggested a strong correlation be-
tween G-CSF and IOP elevation. Recently, Freedman
and Iserovich [28] have reported that IOP is a potential
stimulus for cytokine production. Huang’s report [9]
suggests that the IOP itself may be responsible for the
production of cytokines. However, in this study the find-
ing was only G-CSF was correlated with IOP. That’s dif-
ferent with the findings by Huang et al. who have found
that IL-8, MCP-3, and VEGF also correlated with IOP
besides G-CSF. Lots of reports suggest that the relation-
ship between IOP and inflammation is complex. IOP
elevation may cause disruption of the blood–aqueous
barrier, thereby resulting in production of cytokines
in aqueous humor [29]. The inflammatory cells and
proteins can result in the formation of posterior syne-
chiae leading to peripheral anterior synechiae and
even IOP elevation [30]. To analyze the deep reasons
for the differences with previous studies, the main
reason maybe the high-efficiency of statistical method.
It’s obvious that fellow eye comparison can test the
results more effectively than other way. The present
study may suggest PACS eyes G-CSF has played more
important role than other cytokines in APAC eyes,
and other influencing factors may also play important
roles.
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Previous studies have revealed that conjunctival in-
flammation can be developed in eyes treated with topical
antiglaucoma medication [31]. Particularly, conjunctival
inflammatory infiltrates may be caused by high cumula-
tive antiglaucoma treatments [32, 33]. Similar histo-
pathological effects of antiglaucomatous drugs may also
happened in the trabecular meshwork [34]. What about
the effects of topical glaucoma medications on inflam-
matory cytokine expression? Engel et al’s reported that
preoperative IOP-lowering eye drops did not signifi-
cantly alter the anterior chamber milieu in POAG [35].
The number of glaucoma medications was positively
correlated with G-CSF, IL-6, and IL-8. Topical glaucoma
medications may take more important effects on con-
junctival inflammation than the inflammation in aque-
ous humor.
Lastly, in a study such as the present one, which in-
volve the simultaneous analysis of multiple factors from
each sample, some factors such as sample size and
method of data analysis may affect the outcome. The
Bonferroni correction was applied in the present case.
This is a conservative statistical adjustment used for the
verification of data observations but it may mask poten-
tial changes in exploratory studies. Some potential limi-
tations in our study should also be mentioned. Use of
topical anti-glaucoma medications may influence the
aqueous immune milieu [7]. Another limit of the study
is the sample size: the number of patients enrolled into
our study was relatively low. Nevertheless, the results
were statistically significant, so the relatively small num-
ber of patients may serve to strengthen the results and
conclusions of the study.
Conclusions
In conclusion, the present study showed that APAC is
associated with changes in the AH cytokine profile.
These findings may support the hypothesis that inflam-
mation and hypoxia may play a key role in the pathogen-
esis of glaucoma. Thus, different cytokine expression in
both eyes of the same patient may help us to understand
the different pathology in APAC and PACS. However,
we can not explain why PACS do not develop into
APAC at the same time or some PACS eyes do not
develop into APAC forever. Further studies will be ne-
cessary to resolve these issues.
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